Cingulate Inc. (NASDAQ: CING)
$0.37
-0.0263 ( -6.59% ) 894.1K
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
Market Data
Open
$0.37
Previous close
$0.40
Volume
894.1K
Market cap
$3.21M
Day range
$0.35 - $0.41
52 week range
$0.28 - $16.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Dec 15, 2023 |
8-k | 8K-related | 13 | Dec 12, 2023 |
8-k | 8K-related | 14 | Nov 28, 2023 |
8-k | 8K-related | 13 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
10-q | Quarterly Reports | 69 | Nov 13, 2023 |
8-k | 8K-related | 13 | Nov 03, 2023 |
8-k | 8K-related | 45 | Oct 19, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |
def | Proxies and info statements | 3 | Oct 02, 2023 |